ENDO INTERNATIONAL PLC (ENDP) Stock Price, Quote, News and Overview
NASDAQ:ENDP - Nasdaq - IE00BJ3V9050 - Common Stock - Currency: USD
ENDP Quote, Performance and Key Statistics
0.2926
-0.02 (-5%)
The current stock price of ENDP is 0.2926 USD. In the past month the price decreased by -45.05%. In the past year, price decreased by -87.39%.
ENDP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About ENDP
Company Profile
Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 3,103 full-time employees. The company went IPO on 2014-03-03. The firm operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection. The firm's Generic Pharmaceuticals segment consists of a product portfolio, including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic and sprays.
Company Info
ENDO INTERNATIONAL PLC
First Floor, Minerva House, Simmonscourt Road, Dublin 4
DUBLIN DUBLIN 19355 IE
CEO: Blaise Coleman
Employees: 3103
Company Website: http://www.endo.com/
Phone: 35312682000.0
ENDO INTERNATIONAL PLC / ENDP FAQ
What is the stock price of ENDO INTERNATIONAL PLC today?
The current stock price of ENDP is 0.2926 USD. The price decreased by -5% in the last trading session.
What is the ticker symbol for ENDO INTERNATIONAL PLC stock?
The exchange symbol of ENDO INTERNATIONAL PLC is ENDP and it is listed on the Nasdaq exchange.
On which exchange is ENDP stock listed?
ENDP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENDO INTERNATIONAL PLC stock?
7 analysts have analysed ENDP and the average price target is 1.02 USD. This implies a price increase of 248.6% is expected in the next year compared to the current price of 0.2926. Check the ENDO INTERNATIONAL PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENDO INTERNATIONAL PLC worth?
ENDO INTERNATIONAL PLC (ENDP) has a market capitalization of 68.80M USD. This makes ENDP a Micro Cap stock.
How many employees does ENDO INTERNATIONAL PLC have?
ENDO INTERNATIONAL PLC (ENDP) currently has 3103 employees.
What are the support and resistance levels for ENDO INTERNATIONAL PLC (ENDP) stock?
ENDO INTERNATIONAL PLC (ENDP) has a resistance level at 0.31. Check the full technical report for a detailed analysis of ENDP support and resistance levels.
Is ENDO INTERNATIONAL PLC (ENDP) expected to grow?
The Revenue of ENDO INTERNATIONAL PLC (ENDP) is expected to decline by -18.43% in the next year. Check the estimates tab for more information on the ENDP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ENDO INTERNATIONAL PLC (ENDP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENDP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENDP, evaluating the profitability, health, valuation and growth aspects
- ENDO INTERNATIONAL PLC (ENDP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENDO INTERNATIONAL PLC (ENDP) Sales and EPS estimates to see what analysts future expectations are.
- ENDO INTERNATIONAL PLC (ENDP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENDO INTERNATIONAL PLC (ENDP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENDO INTERNATIONAL PLC (ENDP) Stock Chart to make your own analysis
- ENDO INTERNATIONAL PLC (ENDP) Latest news and press-releases to stay up to date.
Does ENDO INTERNATIONAL PLC (ENDP) stock pay dividends?
ENDP does not pay a dividend.
When does ENDO INTERNATIONAL PLC (ENDP) report earnings?
ENDO INTERNATIONAL PLC (ENDP) will report earnings on 2022-11-07.
What is the Price/Earnings (PE) ratio of ENDO INTERNATIONAL PLC (ENDP)?
The PE ratio for ENDO INTERNATIONAL PLC (ENDP) is 0.13. This is based on the reported non-GAAP earnings per share of 2.33 and the current share price of 0.2926 USD. Check the full fundamental report for a full analysis of the valuation metrics for ENDP.
ENDP Technical Analysis
ENDP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENDP. ENDP may be in some trouble as it scores bad on both profitability and health.
ENDP Financial Highlights
Over the last trailing twelve months ENDP reported a non-GAAP Earnings per Share(EPS) of 2.33. The EPS decreased by -12.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -93.31% | ||
| ROA | -40.81% | ||
| ROE | N/A | ||
| Debt/Equity | -2.52 |
ENDP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to ENDP. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -57.56% and a revenue growth -18.43% for ENDP